3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Sleep Initiation and Maintenance Disorders
1
Pain
1
Ovarian Neoplasms
1
Neuropathy, Painful
1
Neuralgia
1
Hematologic Neoplasms
1
Glioma
1
Chronic Pain
1
Cervical Adenocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Anatomic Stage I Breast Cancer AJCC v8
1
Agnosia
1
Interventions
Surveys and Questionnaires
3
Lidocaine
2
Ketamine
2
Educational Status
2
Dexmedetomidine
2
ziconotide
1
siltuximab
1
erenumab
1
Yoga
1
Telemedicine
1
Standard of Care
1
Sodium Chloride
1
Saline Solution
1
Phlebotomy
1
Patient Education as Topic
1
Pain Management
1
Nalbuphine
1
Motivational Interviewing
1
Morphine
1
Control Groups
1
Cognitive Behavioral Therapy
1
Bupivacaine
1
Botulinum Toxins, Type A
1
Anesthesia, General
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chronic Pain
×
Yoga
×
1 year
×
Clear all
NCT05121558
2026-02-06
YCT
Dana-Farber Cancer Institute
Phase NA
Active not recruiting
227 enrolled